DEA schedule
Is midazolam a controlled substance?
Federal schedule for midazolam from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Midazolam is a Schedule IV controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Midazolam (Schedule IV).
Run it in Rivvi
Which 2027 plans near you dropped or restricted midazolam?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 76 prescription listings from 25 labelers, all Schedule IV |
| DEA controlled substances list | Midazolam: Schedule IV |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Midazolam | 2884 | IV | No | Versed | Listed by name |
Midazolam NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 44567-610 | Midazolam in Sodium Chloride | injection, solution | 1 mg/mL | WG Critical Care, LLC. | CIV |
| 44567-611 | Midazolam in Sodium Chloride | injection, solution | 1 mg/mL | WG Critical Care, LLC. | CIV |
| 71053-595 | N/A | injection, solution | 10 mg/.7mL | Rafa Laboratories, Ltd. | CIV |
| 50474-500 | Nayzilam | spray | 5 mg/.1mL | UCB, Inc. | CIV |
| 0404-9780 | Midazolam | injection | 1 mg/mL | Henry Schein, Inc. | CIV |
| 0404-9913 | Midazolam | injection | 1 mg/mL | Henry Schein, Inc. | CIV |
| 0641-6056 | Midazolam | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6057 | Midazolam | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6059 | Midazolam | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6209 | Midazolam | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6210 | Midazolam | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6220 | Midazolam | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6281 | Midazolam | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 72572-430 | Midazolam | injection | 1 mg/mL | Civica, Inc. | CIV |
| 72572-432 | Midazolam | injection | 1 mg/mL | Civica, Inc. | CIV |
| 0404-9801 | Midazolam | injection | 5 mg/mL | Henry Schein, Inc. | CIV |
| 0641-6060 | Midazolam | injection | 5 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6061 | Midazolam | injection | 5 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6063 | Midazolam | injection | 5 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6190 | Midazolam | injection | 5 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6211 | Midazolam | injection | 5 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6218 | Midazolam | injection | 5 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0641-6219 | Midazolam | injection | 5 mg/mL | Hikma Pharmaceuticals USA Inc. | CIV |
| 0409-0001 | Midazolam | injection, solution | 1 mg/mL | Hospira, Inc. | CIV |
| 0409-2305 | MIDAZOLAM | injection, solution | 1 mg/mL | Hospira, Inc. | CIV |
| 0409-2305 | Midazolam | injection, solution | 1 mg/mL | Hospira, Inc. | CIV |
| 0409-2587 | Midazolam | injection, solution | 1 mg/mL | Hospira, Inc. | CIV |
| 25021-655 | midazolam | injection, solution | 1 mg/mL | Sagent Pharmaceuticals | CIV |
| 42571-414 | Midazolam | injection, solution | 1 mg/mL | Micro Labs Limited | CIV |
| 55154-4743 | Midazolam | injection, solution | 1 mg/mL | Cardinal Health 107, LLC | CIV |
| 63323-411 | Midazolam | injection, solution | 1 mg/mL | Fresenius Kabi USA, LLC | CIV |
| 83270-170 | Midazolam | injection, solution | 1 mg/mL | Onesource Specialty Pharma Limited | CIV |
| 83270-171 | Midazolam | injection, solution | 1 mg/mL | Onesource Specialty Pharma Limited | CIV |
| 83270-174 | Midazolam | injection, solution | 1 mg/mL | Onesource Specialty Pharma Limited | CIV |
| 76045-003 | Midazolam | injection, solution | 10 mg/2mL | Fresenius Kabi USA, LLC | CIV |
| 70069-816 | Midazolam | injection, solution | 2 mg/2mL | SOMERSET THERAPEUTICS, LLC | CIV |
| 70518-4328 | Midazolam | injection, solution | 2 mg/2mL | REMEDYREPACK INC. | CIV |
| 76045-001 | Midazolam | injection, solution | 2 mg/2mL | Fresenius Kabi USA, LLC | CIV |
| 76045-211 | Midazolam | injection, solution | 2 mg/2mL | Fresenius Kabi USA, LLC | CIV |
| 70069-817 | Midazolam | injection, solution | 5 mg/5mL | SOMERSET THERAPEUTICS, LLC | CIV |
Showing 40 of 76 listings.
Questions
Is midazolam a controlled substance?
Yes. Midazolam is a Schedule IV controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Midazolam (Schedule IV).
Is midazolam a narcotic?
No. The DEA list does not mark midazolam as a narcotic (NARC = N) and places it in Schedule IV. Its FDA established pharmacologic class is Benzodiazepine.
What schedule is midazolam?
Midazolam is Schedule IV in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Midazolam
- What is Midazolam used for?FDA label uses
- Generic for VersedFDA Orange Book
- Generic for NayzilamFDA Orange Book
- What is Nayzilam used for?FDA label uses
- Is Nayzilam a controlled substance?Schedule IV
- Benzodiazepines listFDA drug class
- NDC 44567-610Midazolam NDC record
- NDC 44567-611Midazolam NDC record
- NDC 50474-500Midazolam NDC record
- Schedule IV drugs listDEA schedule